Filing Details
- Accession Number:
- 0001645470-19-000041
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-07-10 16:55:03
- Reporting Period:
- 2019-06-28
- Accepted Time:
- 2019-07-10 16:55:03
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1528172 | Endonovo Therapeutics Inc. | ENDV | Pharmaceutical Preparations (2834) | 452552528 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1645470 | Brian Alan Collier | 6320 Canoga Avenue 15Th Floor Woodland Hills CA 91367 | Ceo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-06-28 | 10,000 | $0.02 | 24,439,097 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-06-28 | 6,012 | $0.02 | 24,445,109 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-06-28 | 43,988 | $0.02 | 24,488,097 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-06-28 | 5,000 | $0.02 | 24,493,097 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-06-28 | 25,000 | $0.02 | 24,518,097 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-06-28 | 5,000 | $0.02 | 24,523,097 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-06-28 | 25,000 | $0.02 | 24,548,097 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-07-01 | 5,000 | $0.02 | 24,553,097 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-07-01 | 10,000 | $0.02 | 24,563,097 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-07-01 | 15,000 | $0.02 | 24,578,097 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-07-01 | 20,000 | $0.02 | 24,598,097 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-07-01 | 2,000 | $0.02 | 24,600,097 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-07-01 | 20,000 | $0.02 | 24,620,097 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-07-02 | 20,000 | $0.02 | 24,640,097 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-07-02 | 20,000 | $0.02 | 24,660,097 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-07-02 | 2,000 | $0.02 | 24,662,097 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-07-03 | 5,000 | $0.02 | 24,667,097 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-07-03 | 1,000 | $0.02 | 24,668,097 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-07-03 | 10,000 | $0.02 | 24,678,097 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-07-05 | 5,000 | $0.02 | 24,683,097 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-07-05 | 5,000 | $0.02 | 24,688,097 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-07-05 | 10,000 | $0.02 | 24,698,097 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-07-08 | 5,000 | $0.02 | 24,703,097 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Billionaire Hedge Funds
